Oxytocin: a therapeutic target for mental disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
We review here that oxytocin (OT) is released into blood and within distinct brain regions in response to stressful and social stimuli, and has been shown to have an antidepressant-like effect in animal studies. Clinical reports suggest OT to be a promising drug for psychiatric diseases such as depression, anxiety disorders, schizophrenia, and autism. OT may also have therapeutic potential in the treatment of major depressive disorders, even though OT administered into blood does not readily cross the blood-brain barrier. Physiological functions such as sexual activity and mating induce the release of OT in the central nervous system. A drug for the treatment of sexual dysfunction, sildenafil, enhances the electrically evoked release of OT from the posterior pituitary. This drug has antidepressant-like effects through activation of an OT signaling pathway. These results suggest that sildenafil may have promise as a potential antidepressant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Oxytocin and the Neural Mechanisms Regulating Social Cognition and Affiliative Behavior
Ross, H. E., & Young, L. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.004 · Cited by 856 · cited 1×
“Therefore, OT acts as a neurotransmitter/neuromodulator to regulate a range of CNS functions in males and females, including emotional [6, 7], parental [8–10], affiliative [11, 12], and sexual [2] behaviors, as well as spatial and social memories [1, 5].”
Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice
Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., Yanagisawa, T., Kimura, T., Matzuk, M. M., Young, L. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505312102 · Cited by 806
Brain oxytocin: A key regulator of emotional and social behaviours in both females and males
Neumann, I. D. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01726.x · Cited by 743 · cited 1×
“Therefore, OT acts as a neurotransmitter/neuromodulator to regulate a range of CNS functions in males and females, including emotional [6, 7], parental [8–10], affiliative [11, 12], and sexual [2] behaviors, as well as spatial and social memories [1, 5].”
The Neurobiology of Parental Behavior
(2003) · Hormones, Brain, and Behavior · doi:10.1007/b97533 · Cited by 684
CD38 is critical for social behaviour by regulating oxytocin secretion
Jin, D., Liu, H.-X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., Shnayder, N. A., Yamada, K., Noda, M., Seike, T., et al. (2007) · Nature · doi:10.1038/nature05526 · Cited by 665 · cited 1×
“Therefore, OT acts as a neurotransmitter/neuromodulator to regulate a range of CNS functions in males and females, including emotional [6, 7], parental [8–10], affiliative [11, 12], and sexual [2] behaviors, as well as spatial and social memories [1, 5].”
Plasma oxytocin increases in the human sexual response
CARMICHAEL, M. S., HUMBERT, R., DIXEN, J., PALMISANO, G., GREENLEAF, W., & DAVIDSON, J. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-27 · Cited by 554 · cited 1×
“Although sexual activity and mating are accompanied by a high level of arousal, anecdotal and experimental evidence demonstrates that sedation and calmness are common in the post-coital period in humans [22, 32, 33].”
A negative regulator of MAP kinase causes depressive behavior
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine · doi:10.1038/nm.2219 · Cited by 412 · cited 1×
“Increases in neurogenesis, neuronal plasticity, and survival through the activation of a MAP kinase cascade and subsequent enhanced phosphorylation of cAMP response element-binding protein (CREB) in the hippocampus have been proposed as common mediators of antidepressant efficacy [38–40].”
Baskerville, T. A., & Douglas, A. J. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00154.x · Cited by 377 · cited 3×
“The OT receptor (OTR), a member of the G protein-coupled receptor family, is expressed widely in the central nervous system (CNS), especially in the ventromedial nucleus of the hypothalamus, the central nucleus of the amygdala, the head of the caudate-putamen and the hippocampus [2, 5].”
Skrundz, M., Bolten, M., Nast, I., Hellhammer, D. H., & Meinlschmidt, G. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.74 · Cited by 349 · cited 1×
“Moreover, plasma OT concentration during pregnancy is associated with the development of postpartum depression [31].”
Cited by
Four decades of research on alexithymia: moving toward clinical applications
Samur, D., Tops, M., Schlinkert, C., Quirin, M., Cuijpers, P., & Koole, S. L. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00861 · Cited by 104
Sack, M., Spieler, D., Wizelman, L., Epple, G., Stich, J., Zaba, M., & Schmidt, U. (2017) · BMC Medicine · doi:10.1186/s12916-017-0801-0 · Cited by 57
Hashemi, F., Tekes, K., Laufer, R., Szegi, P., Tóthfalusi, L., & Csaba, G. (2013) · Reproductive Sciences · doi:10.1177/1933719113483010 · Cited by 36
Anxiolytic drug discovery: What are the novel approaches and how can we improve them?
Stewart, A. M., & Kalueff, A. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.857309 · Cited by 22
“Largely known for its powerful influence on the regulation of social behavior in several species [47,52,134] (including humans [134-136]), continuously growing research further implicates OT as a robust anxiolytic [137-139].”
Background
Metadata
- Authors
- Matsuzaki, M., Matsushita, H., Tomizawa, K., & Matsui, H.
- Venue
- The Journal of Physiological Sciences
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 62
- Issue
- 6
- Pages
- 441-444
- ISSN
- 1880-6546 (ISSN-L)
- OpenAlex
- W2043520624
- Cited by
- 79
- References
- 16
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxytocin: a therapeutic target for mental disorders. https://app.cochat.ai/papers/10.1007/s12576-012-0232-9
- The paper
- Matsuzaki, M., Matsushita, H., Tomizawa, K., & Matsui, H. (2012). Oxytocin: a therapeutic target for mental disorders. The Journal of Physiological Sciences. https://doi.org/10.1007/s12576-012-0232-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.